Valneva (VALN) News Today → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free VALN Stock Alerts $8.88 +0.07 (+0.79%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | marketbeat.comValneva (NASDAQ:VALN) Stock Price Up 8.5%Valneva (NASDAQ:VALN) Trading Up 8.5%May 14, 2024 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Up to $7.61Valneva (NASDAQ:VALN) Shares Gap Up to $7.61May 13, 2024 | msn.comValneva Seeks Expanded Use For Its Chikungunya Vaccine In Adolescents With Encouraging Phase 3 DataMay 13, 2024 | msn.comVALN Stock Earnings: Valneva Misses EPS, Misses Revenue for Q1 2024May 13, 2024 | americanbankingnews.comValneva SE (NASDAQ:VALN) Expected to Post Q2 2024 Earnings of ($0.47) Per ShareMay 13, 2024 | globenewswire.comValneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya VaccineMay 12, 2024 | americanbankingnews.comValneva (NASDAQ:VALN) Stock Rating Reaffirmed by HC WainwrightMay 10, 2024 | msn.comHealth officials issue warning over outbreaks of virus: 'Poses a significant risk'May 8, 2024 | marketbeat.comValneva (NASDAQ:VALN) Earns "Buy" Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $26.00 price objective on shares of Valneva in a research report on Wednesday.May 7, 2024 | markets.businessinsider.comWhat Wall Street expects from Valneva SE (spons ADRs)'s earningsMay 7, 2024 | markets.businessinsider.comValneva earnings preview: what to expectMay 7, 2024 | finance.yahoo.comValneva Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesMay 7, 2024 | globenewswire.comValneva Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesMay 6, 2024 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Down to $7.71Valneva (NASDAQ:VALN) Shares Gap Down to $7.71May 6, 2024 | finance.yahoo.comDeclaration of shares and voting rights April 30, 2024 - VALNEVA SEMay 2, 2024 | marketbeat.comValneva (NASDAQ:VALN) Sees Unusually-High Trading VolumeValneva (NASDAQ:VALN) Sees Large Volume IncreaseApril 29, 2024 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Down to $7.64Valneva (NASDAQ:VALN) Shares Gap Down to $7.64April 29, 2024 | ft.comLyme disease bites as ticks gain ground in USApril 25, 2024 | marketbeat.comValneva (NASDAQ:VALN) Sees Large Volume IncreaseValneva (NASDAQ:VALN) Sees Strong Trading VolumeApril 19, 2024 | marketbeat.comValneva (NASDAQ:VALN) Shares Down 3.9% Valneva (NASDAQ:VALN) Stock Price Down 3.9%April 18, 2024 | marketbeat.comValneva (NASDAQ:VALN) Trading 6.1% Higher Valneva (NASDAQ:VALN) Shares Up 6.1%April 16, 2024 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Down to $8.50Valneva (NASDAQ:VALN) Shares Gap Down to $8.50April 11, 2024 | marketbeat.comValneva (NASDAQ:VALN) Stock Price Up 4.3%Valneva (NASDAQ:VALN) Shares Up 4.3%April 9, 2024 | marketbeat.comValneva (NASDAQ:VALN) Trading Down 6.6%Valneva (NASDAQ:VALN) Stock Price Down 6.6%April 4, 2024 | finance.yahoo.comDeclaration of voting rights - Valneva SE, March 2024April 3, 2024 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Up to $7.72Valneva (NASDAQ:VALN) Shares Gap Up to $7.72April 1, 2024 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Down to $7.92Valneva (NASDAQ:VALN) Shares Gap Down to $7.92March 29, 2024 | marketbeat.comShort Interest in Valneva SE (NASDAQ:VALN) Increases By 49.8%Valneva SE (NASDAQ:VALN - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 42,400 shares, an increase of 49.8% from the February 29th total of 28,300 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average daily trading volume, of 10,000 shares, the short-interest ratio is presently 4.2 days.March 27, 2024 | msn.comValneva commences Phase I trial of second-generation Zika vaccineMarch 27, 2024 | marketbeat.comValneva (NASDAQ:VALN) Stock Price Down 4.1%Valneva (NASDAQ:VALN) Trading Down 4.1%March 27, 2024 | markets.businessinsider.comBuy Rating on Valneva Supported by Promising Vaccine Developments and Solid Revenue ProjectionsMarch 26, 2024 | globenewswire.comValneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine CandidateMarch 25, 2024 | msn.com2 new Lyme disease vaccines could mean end of debilitating illnessMarch 25, 2024 | globenewswire.comValneva Announces Filing of 2023 Universal Registration Document and US Form 20-FMarch 22, 2024 | seekingalpha.comValneva SE (VALN) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | markets.businessinsider.comWhat Analysts Are Saying About Valneva StockMarch 22, 2024 | marketbeat.comValneva (NASDAQ:VALN) PT Lowered to $17.00Guggenheim cut their target price on Valneva from $18.00 to $17.00 and set a "buy" rating on the stock in a research note on Friday.March 21, 2024 | markets.businessinsider.comBuy Rating Affirmed for Valneva: Strong Core Growth and Strategic Financial HealthMarch 21, 2024 | finance.yahoo.comValneva SE (NASDAQ:VALN) Q4 2023 Earnings Call TranscriptMarch 21, 2024 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Up to $7.10Valneva (NASDAQ:VALN) Shares Gap Up to $7.10March 21, 2024 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Valneva (NASDAQ:VALN)HC Wainwright reissued a "buy" rating and set a $26.00 target price on shares of Valneva in a research note on Thursday.March 21, 2024 | globenewswire.comValneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th World Vaccine Congress in Washington D.C.March 20, 2024 | msn.comValneva guides for nearly double product sales by 2026March 20, 2024 | investorplace.comVALN Stock Earnings: Valneva Misses Revenue for Q4 2023March 20, 2024 | msn.comValneva GAAP EPS of -€0.73, revenue of €153.71M; updates FY24 guidanceMarch 20, 2024 | finance.yahoo.comValneva Reports Full Year 2023 Results and Provides Business Updates and OutlookMarch 20, 2024 | reuters.comFrench biotech company Valneva raises product sales guidanceMarch 20, 2024 | globenewswire.comValneva Reports Full Year 2023 Results and Provides Business Updates and OutlookMarch 19, 2024 | msn.comWest Lothian sciences firm bags brace of awardsMarch 19, 2024 | marketbeat.comValneva (NASDAQ:VALN) Trading 7.4% Higher Valneva (NASDAQ:VALN) Stock Price Up 7.4% Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. VALN Media Mentions By Week VALN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VALN News Sentiment▼-0.040.42▲Average Medical News Sentiment VALN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VALN Articles This Week▼63▲VALN Articles Average Week Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADPT News CABA News ITOS News ALEC News EXAI News ALLO News TSHA News FATE News EDIT News HLVX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VALN) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist My Default Watchlist Adding Valneva SE You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
